09
Search and Filter
Results per Page:
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine
Study result moves scientists closer to developing elusive HIV vaccine
Fred Hutch pioneer Dr. Beverly Torok-Storb dies
Beloved mentor and bone marrow biologist created pathways for both blood cancer cures and marginalized students
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant
Study involving 22 U.S. cancer centers and research institutions is one of the largest analyses of vaccination for any pathogen within the first year after bone marrow transplant
Dr. Philip Greenberg elected to National Academy of Sciences
Fred Hutch expert in immunology has led development of T-cell therapies for cancer
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Project Stella enables novel pediatric AML immunotherapies, potential cure
Fred Hutch's Dr. Soheil Meshinchi's lab identifies potential drug while also developing immunotherapy thanks to fundraising
Brain cancer expert Dr. Eric Holland receives Endowed Chair in Cancer Biology
Chair recognizes comprehensive vision, contributions to solid tumor research
Fred Hutch study highlights racial disparities in ovarian cancer risk for women
Researchers examined risks for Black and white women with endometriosis and fibroids to understand how common medical interventions for those conditions modified the outcomes
Building health equity in big ways and small
Pathways to Equity Symposium highlights need for individual efforts, community collaborations and systemic change to improve outcomes
Social workers illustrate the Heart of the Hutch
Hundreds of people keep Fred Hutch science and support services going. Here are some of their stories.
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous
Bladder cells’ strategy blocks cancer-causing genetic programs, could be new therapeutic target
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
Going long: Viruses linger with lasting impact
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should ‘long COVID’ surprise us?
Melding data creates wider landscape of brain cancer
New computational visualization tool allows researchers to compare different tumor types, normal brain tissue, pinpoint cancer-promoting alterations